Lulicon luliconazole: Phase II started

Topica (formerly Janus Pharmaceuticals Inc.) began a double-blind, vehicle-controlled, U.S. Phase II trial to evaluate 1% luliconazole cream given once daily for 14 or 28 days in about 120 patients. ...